Predictive Oncology Inc. financial data

Symbol
POAI on Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
91 43 Rd Street, Suite 110, Pittsburgh, PA
State of incorporation
DE
Fiscal year end
December 31
Former names
Precision Therapeutics Inc. (to 6/4/2019), Skyline Medical Inc. (to 2/6/2018), BioDrain Medical, Inc. (to 8/7/2013)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 166 % -64%
Quick Ratio 11.8 % +12.9%
Debt-to-equity 134 % +285%
Return On Equity -304 % -175%
Return On Assets -130 % -58.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.67M shares +64.1%
Common Stock, Shares, Outstanding 6.67M shares +65.3%
Entity Public Float 19M USD -40.8%
Common Stock, Value, Issued 66.7K USD +65.3%
Weighted Average Number of Shares Outstanding, Basic 6.4M shares +58.7%
Weighted Average Number of Shares Outstanding, Diluted 6.4M shares +58.7%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 188K USD -41.2%
Selling and Marketing Expense 1.65M USD +4.05%
General and Administrative Expense 8.39M USD -19.6%
Operating Income (Loss) -13.7M USD +24.6%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -14M USD +24.2%
Earnings Per Share, Basic -3.06 USD/shares +34.2%
Earnings Per Share, Diluted -0.05 USD/shares +37.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.08M USD -74.2%
Accounts Receivable, after Allowance for Credit Loss, Current 464K USD -14.9%
Inventory, Net 504K USD +14.6%
Assets, Current 4.57M USD -66.2%
Property, Plant and Equipment, Net 403K USD -71.1%
Operating Lease, Right-of-Use Asset 2.2M USD -23.2%
Intangible Assets, Net (Excluding Goodwill) 221K USD -14.6%
Goodwill 0 USD -100%
Other Assets, Noncurrent 103K USD -17.4%
Assets 7.5M USD -58.7%
Accounts Payable, Current 1.14M USD -2.25%
Accrued Liabilities, Current 1.52M USD -16.2%
Contract with Customer, Liability, Current 257K USD -31.4%
Liabilities, Current 3.82M USD -8.51%
Operating Lease, Liability, Noncurrent 1.7M USD -27.3%
Other Liabilities, Noncurrent 10K USD
Liabilities 5.53M USD -15.1%
Retained Earnings (Accumulated Deficit) -178M USD -8.5%
Stockholders' Equity Attributable to Parent 1.97M USD -83.1%
Liabilities and Equity 7.5M USD -58.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.42M USD +0.34%
Net Cash Provided by (Used in) Financing Activities -112K USD
Net Cash Provided by (Used in) Investing Activities -3.03K USD +93.5%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.53M USD -1.64%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.74K USD
Deferred Tax Assets, Valuation Allowance 24.5M USD -69.7%
Deferred Tax Assets, Gross 25.2M USD -68.8%
Operating Lease, Liability 2.2M USD -24.1%
Depreciation 618K USD -7.68%
Payments to Acquire Property, Plant, and Equipment 3.03K USD -87.6%
Lessee, Operating Lease, Liability, to be Paid 2.71M USD -27.3%
Property, Plant and Equipment, Gross 2.63M USD -45.5%
Operating Lease, Liability, Current 497K USD -10.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 804K USD -6.29%
Lessee, Operating Lease, Liability, to be Paid, Year One 798K USD -10%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure +8.33%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 505K USD -38.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 828K USD +3.01%
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 139K USD -83.2%
Additional Paid in Capital 180M USD +2.42%
Amortization of Intangible Assets 27.5K USD -77.9%
Depreciation, Depletion and Amortization 163K USD -31.7%
Share-based Payment Arrangement, Expense -6.52K USD -108%